The Business Of Neurotech

The Business Of Neurotech

Adam Fraser
Country USA
Language EN-US
Episodes 7
Latest 16.11.2026

The Business of Neurotech is a podcast that explores the commercial side of neuroscience, covering topics like neuromodulation, brain-computer interfaces, and medical devices. Hosted by Adam Fraser, it features interviews with founders, CEOs, venture capitalists, and strategic leaders. The show discusses market maturity, regulatory challenges, and go-to-market strategies for neurotechnology. It is aimed at investors, researchers, and entrepreneurs interested in the business of brain tech.

Episodes

  • Dorian Haci talks Neurotech Chips and BCI
    Dorian Haci talks Neurotech Chips and BCI 16.11.2026 40m
    What will it take to make neurotechnology part of everyday life? In this episode, Adam Fraser is joined by Dorian Haci, co-founder and CEO of MintNeuro, to explore the business behind the chips that power neural devices and BCIs. In their conversation, Dorian shares his perspective on building a company that helps other innovators move forward and turns scientific ambition into something people can use. They explore his ambition to make neurotech more accessible, the importance of creating re...
  • Daniel Månsson Talks tDCS, Depression and Scaling a Start Up
    Daniel Månsson Talks tDCS, Depression and Scaling a Start Up 02.11.2026 35m
    Flow Neuroscience has developed an at-home brain stimulation treatment for depression, but bringing it to market has involved years of clinical research, regulatory approvals, and commercial challenges. In this episode of the Business of Neurotech Podcast, host Adam Fraser welcomes Daniel Månsson, Co-founder and CEO of Flow Neuroscience, to explore the story behind the technology and the company's expansion into the U.S. market. Daniel explains how his background in clinical psychology led hi...
  • Chay Carter Talks Neurotech Recruitment and Market Trends
    Chay Carter Talks Neurotech Recruitment and Market Trends 19.10.2026 39m
    What can the people building neurotech teams tell us about where the industry is heading? In this episode of The Business of Neurotech, Adam Fraser speaks with Chay Carter, founder of Carter Sciences and co-founder of reccy neuro, to offer a recruitment-focused view of the sector. Chay brings decades of experience in recruitment and psychology, combining specialist hiring with research, newsletters and insights from the people developing the technology. In their conversation, Chay shares how ...
  • Paul Le Floch talks BCI, Coma and Start Up Dynamics
    Paul Le Floch talks BCI, Coma and Start Up Dynamics 05.10.2026 38m
    How can softer materials make implantable brain-computer interfaces safer, more stable and clinically useful? In this episode of The Business of Neurotech, Adam Fraser is joined by Dr Paul Le Floch, co-founder and CEO of Axoft, to explore how his materials science background led to Fleuron, a soft neural interface platform designed to reach deep brain regions while maintaining high-density recordings. Dr Le Floch explains why Axoft is initially focusing on disorders of consciousness, how the ...
  • Jordan DeKraker Talks Seed Funding, Brain AI and Epilepsy
    Jordan DeKraker Talks Seed Funding, Brain AI and Epilepsy 21.09.2026 38m
    How can academic brain-imaging research become a practical clinical tool for people with drug-resistant epilepsy? In this episode of The Business of Neurotech, Adam Fraser is joined by Jordan DeKraker, co-founder and CEO of BrainScores and a postdoctoral researcher at the Montreal Neurological Institute, to discuss how he went from hippocampal mapping to building an AI-enabled neuroimaging company. In their conversation, Jordan talks about how his personal experience with epilepsy sharpened t...
  • Matt Angle Talks Paradromics and BCI Market Dynamics
    Matt Angle Talks Paradromics and BCI Market Dynamics 07.09.2026 43m
    For people who have lost the ability to speak, brain-computer interfaces (BCIs) could open a new path back to communication. In this episode, Adam Fraser speaks with Matt Angle, founder and CEO of Paradromics, about the company’s 11-year journey to build a BCI that can restore communication for people who have lost it. Matt explains why moving more neural data is central to BCI performance and how Paradromics is approaching safety, durability and clinical translation. He breaks down why speec...
  • Derrick Buchanan talks Stanford, Transcranial Magnetic Stimulation and Neurotech
    Derrick Buchanan talks Stanford, Transcranial Magnetic Stimulation and Neurotech 24.08.2026 44m
    Brain stimulation is moving from specialist clinics towards faster, more personalised and scalable care. In this episode, Adam Fraser speaks with Dr Derrick Buchanan, a clinical neuroscientist in Stanford’s Brain Stimulation Lab, entrepreneur, author and speaker whose work spans precision brain imaging, neuromodulation and mental health. Derrick discusses his path from Canada to Stanford and explores how the university turns research into companies. He unpacks how transcranial magnetic stimul...
  • Matias Serebrinsky talks frontier brain and mental health VC investing
    Matias Serebrinsky talks frontier brain and mental health VC investing 10.08.2026 39m
    What makes an emerging technology bold enough and a founder exceptional enough to justify taking an early-stage risk? In this episode of The Business of Neurotech, Adam Fraser sits down with Matias Serebrinsky, Founding Partner at PsyMed Ventures, a specialist venture capital fund investing in frontier brain and mental health technologies. Matias brings a dual perspective as both a former startup founder and an early-stage investor who previously supported AI companies during a pivotal period...
  • Richard Mulry Talks Health System Venture Capital and Neurotech Investing
    Richard Mulry Talks Health System Venture Capital and Neurotech Investing 27.07.2026 40m
    How do you turn promising neurotechnology into solutions that can actually work inside healthcare systems? In this episode of The Business of Neurotech Podcast, Adam Fraser is joined by Richard Mulry, President and CEO of Northwell Holdings, the for-profit venture investment arm of Northwell Health, to explore what it takes to identify, invest in, and scale innovation in clinical care. Richard explains why Northwell prefers to invest in companies it would use itself, and how clinical evidence...
  • Nicolas Vachicouras Talks BCI Market Dynamics and Start Up Life
    Nicolas Vachicouras Talks BCI Market Dynamics and Start Up Life 13.07.2026 37m
    What does it take to build a BCI company around better hardware, stronger data, and a long-term view of how the brain will be decoded? In this episode of The Business of Neurotech, host Adam Fraser is joined by Nicolas Vachicouras, CEO and co-founder of Neurosoft Bioelectronics, to discuss his path from microelectronics and nanotechnology into the BCI space, and how Neurosoft is developing soft, stretchable electrodes designed to sit on the brain surface rather than penetrate it. Adam and Nic...
  • Ryan Field Talks Kernel and Neuroscience as a Service
    Ryan Field Talks Kernel and Neuroscience as a Service 29.06.2026 38m
    What does it take to build a brain measurement company from the ground up and turn neuroscience into a scalable service? In this episode of The Business of Neurotech, host Adam Fraser is joined by Ryan Field, CEO of Kernel, to talk about what it means to build brain technology in an emerging market. Adam and Ryan discuss Ryan’s path from electrical engineering and sensing technology into neurotech, and how Kernel has evolved from an early invasive BCI vision into a company focused on non-inva...
  • David Eagleman Talks Media, Startups, and Neuroscience
    David Eagleman Talks Media, Startups, and Neuroscience 15.06.2026 41m
    How do you turn neuroscience ideas into real businesses without losing sight of the science? In this episode of The Business of Neurotech, host Adam Fraser sits down with neuroscientist, author, podcaster, entrepreneur, and Stanford educator David Eagleman to explore his journey across academia and neurotech startups. David discusses how he shifted from running a traditional neuroscience lab to building ventures in sensory substitution, digital cognitive assessment, and companion robotics, an...
  • Naveen Rao Talks Neurotech Market Dynamics
    Naveen Rao Talks Neurotech Market Dynamics 01.06.2026 42m
    Where is neurotech money really flowing, and what do the numbers say about where the industry is heading next? In this episode of The Business of Neurotech, host Adam Fraser sits down with Naveen Rao, founder of Patchwise Labs, curator of Neurotech Futures, and Forbes contributor covering neurotechnology’s impact on business and society. In their conversation, Naveen shares how a career spanning public health, health policy, advocacy, and healthcare analysis led him into neurotech and explain...
  • Mariam Khayretdinova talks EEG, AI and Psychiatry
    Mariam Khayretdinova talks EEG, AI and Psychiatry 18.05.2026 39m
    What if the future of psychiatry depended less on subjective questionnaires and more on biological data, scalable brain models, and artificial intelligence? In this episode of The Business of Neurotech, host Adam Fraser sits down with Mariam Khayretdinova, Founder and CEO of Brainify.AI, a company building electroencephalography (EEG) foundation models for precision neuroscience. Mariam brings a mix of applied mathematics, technology, psychology, and lived experience to the discussion, drawin...
  • Amy Kruse Talks Venture Investing in Neurotech
    Amy Kruse Talks Venture Investing in Neurotech 04.05.2026 41m
    What does it take to turn cutting-edge brain science into real-world impact? In this episode of The Business of Neurotech Podcast, host Adam Fraser is joined by Dr Amy Kruse, General Partner and CIO (Chief Investment Officer) at Satori Neuro, whose career spans neuroscience research, DARPA (Defense Advanced Research Projects Agency) program leadership, and venture investing. Dr Kruse shares how her early work in human performance and neurotechnology revealed both the promise and the limitatio...
  • Keith Murphy Talks Focused Ultrasound and Start-Up Life
    Keith Murphy Talks Focused Ultrasound and Start-Up Life 27.04.2026 36m
    Can focused ultrasound finally make deep brain stimulation scalable, non-invasive, and practical for everyday patients? In this episode of The Business of Neurotech, host Adam Fraser sits down with Keith Murphy, co-founder and CTO of Attune Neurosciences, to explore how his path from behavioural neuroscience and optogenetics led to a company building wearable focused ultrasound technology for brain stimulation. Keith explains how Attune is tackling the commercial limits of clinic-based neurom...
  • Michael Brotherton Talks Neurotech Market Dynamics and Neurotech Investing
    Michael Brotherton Talks Neurotech Market Dynamics and Neurotech Investing 22.04.2026 36m
    What does it really take to turn neurotechnology into a scalable business? In this episode of The Business of Neurotech, host Adam Fraser sits down with Michael Brotherton, co-founder and managing partner at Dragonfly 44, to explore the capital, strategy, and market forces shaping the sector. Michael talks about his journey from science into investment banking and how this ultimately led him to establish a business specialising in neuroscience and neurotechnology. He then delves into his defi...

Popular in

The podcast also appears in the podcast charts of these countries.